Biohaven Pharmaceutical Hold
13F holders, Q2 2026 (June 30)1holders
0new positions
0sold out
$14.88avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Biohaven Pharmaceutical Hold in their 13F filings, unchanged from Q1 2026. 0 opened new positions and 0 sold out. The largest holder was Knoll Capital Management, LLC ($35.0M).
- Company
- Biohaven Pharmaceutical Hold
- CUSIP
- G11196105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 23,918 shares bought, net +23,918 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Knoll Capital Management, LLC | 16.33% | Add +1.0% | 2,352,520 | $35.0M |
"% of holder's portfolio" is BIOHAVEN PHARMACEUTICAL HOLD's weight in each manager's 13F, not the share of Biohaven Pharmaceutical Hold the manager owns.